v3.26.1
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Preferred Stock Of the 2,000,000 shares of preferred stock authorized, the Company’s board of directors has designated (all with par value of $0.001 per share) the following:
As of June 30, 2026As of December 31, 2025
Preferred
Shares
Outstanding		Liquidation
Preference
(Per Share)		Total
Liquidation
Preference		Preferred
Shares
Outstanding		Liquidation
Preference
(Per Share)		Total
Liquidation
Preference
Series C-32,000$10.00 $20,000 2,000$10.00 $20,000 
Series E89,623$62.76 $5,624,739 89,623$62.76 $5,624,739 
Total91,623$5,644,739 91,623$5,644,739 
Schedule of Fair Value of the PSUs Granted The following key assumptions were used to determine the fair value of the PSUs granted during the period:
AssumptionPeriod 1 Period 2 Period 3
2025 Grant
Share price$8.10 N/AN/A
Equity volatility71.2 %69.7%87%
Remaining term (years)0.991.992.99
Dividend yield0 %0 %0 %
Risk-free rate4.1 %4.2 %4.3 %
2026 Grant
Share price$7.27 N/AN/A
Equity volatility87.3 %81.8%77.6%
Remaining term (years)1.022.023.02
Dividend yield0 %0 %0 %
Risk-free rate3.5 %3.6 %3.7 %
Schedule of Condensed Consolidated Statements of Operations
Total stock-based compensation expense recognized in the condensed consolidated statements of operations is as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
Award type2026202520262025
RSUs$2,850 $1,398 $6,190 $3,477 
PSUs829 437 1,545 916 
Stock options405 842 931 1,784 
Total$4,084 $2,677 $8,666 $6,177 
Schedule of Stock-Based Compensation Expense by Financial Statement
Three Months Ended
June 30,		Six Months Ended
June 30,
Financial statement line item2026202520262025
Cost of sales$226 $87 $418 $142 
Research and development359 196 637 320 
Selling and marketing556 245 1,178 358 
General and administrative2,943 2,149 6,433 5,357 
Total$4,084 $2,677 $8,666 $6,177